Transaction · 0001022079-26-000089

PREVOZNIK MICHAEL E

PREVOZNIK MICHAEL E, SVP, GC, reported an open-market or private sale at QUEST DIAGNOSTICS INC involving 6237.000000 shares for an estimated $1519504.72. Reported holdings after the transaction were 37987.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SSVP, GC
DGXQUEST DIAGNOSTICS INC
Filing timeAug 31
Trade dateAug 28, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$242.76
Pre-filing
1mo ago -3.1%1w ago +0.7%1d ago +0.8%
Returns since
7d +0.0%30d +0.0%90d +0.0%180d +0.0%1y +0.0%

DGX price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
DGX since 2026-08-31Filed 4 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001022079-26-000089
Common Stock
Transaction date
Aug 28, 2026
Filed Aug 31, 2026, 08:37 PM · 3d delay
Shares
6.23k sh
$24.3k per share
Estimated value
-$151M
Computed from shares × price
Holdings after
37.9k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership Large Sale Repeat Seller 10b5-1 Detected
-4score
Filing-only score

-4

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

SVP & General Counsel

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

  2. F2

    This transaction was executed in multiple trades at prices ranging from $242.270 to $243.269. The price reported above reflects the weighted average sale price. The reporting person hereby undertake…

  3. F3

    This transaction was executed in multiple trades at prices ranging from $243.270 to $244.225. The price reported above reflects the weighted average sale price. The reporting person hereby undertake…

  4. F4

    This transaction was executed in multiple trades at prices ranging from $244.280 to $245.247. The price reported above reflects the weighted average sale price. The reporting person hereby undertake…

  5. F5

    On August 28, 2026, the reporting person made a charitable gift of 1,000 shares, a transaction eligible for deferred reporting on Form 5. The reporting person has chosen to report such transaction ear…

  6. F6

    These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) and/or Supplemental Deferred Compensation Plan. The information was obta…

  7. F7

    The options vested in three equal annual installments beginning on the first annual anniversary of the grant date.

Original filing · 0001022079-26-000089
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

DGX